For the quarter ending 2026-03-31, ADMA made $114,493K in revenue. $45,328K in net income. Net profit margin of 39.59%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 114,493 | 139,163 | 134,224 | 121,984 |
| Cost of product revenue | 33,743 | 50,348 | 58,598 | 54,757 |
| Gross profit | 80,750 | 88,815 | 75,626 | 67,227 |
| Research and development | 2,597 | 1,377 | 1,528 | 1,031 |
| Plasma center operating expenses | 1,062 | 1,126 | 1,272 | 1,152 |
| Amortization of intangible assets | 55 | 49 | 38 | 32 |
| Gain on sale of plasma centers | 7,980 | - | - | - |
| Selling, general and administrative | 26,742 | 23,511 | 21,776 | 22,214 |
| Total operating expenses | 22,476 | 26,063 | 24,614 | 24,429 |
| Income from operations | 58,274 | 62,752 | 51,012 | 42,798 |
| Interest income | - | 487 | 376 | 400 |
| Interest and other income | 1,093 | - | - | - |
| Interest expense | 2,100 | 1,626 | 1,675 | 1,834 |
| Gain on extinguishment of debt | - | 0 | -2,177 | -1,159 |
| Other expense | -140 | -19 | -21 | -108 |
| Other income (expense), net | -1,147 | -1,158 | -3,497 | -2,701 |
| Income before income taxes | 57,127 | 61,594 | 47,515 | 40,097 |
| Provision for income taxes | 11,799 | 12,215 | 11,087 | 5,878 |
| Net income | 45,328 | 49,379 | 36,428 | 34,219 |
| Basic EPS | 0.19 | 0.21 | 0.15 | 0.14 |
| Diluted EPS | 0.19 | 0.204 | 0.15 | 0.14 |
| Basic Average Shares | 236,072,751 | 235,326,927 | 238,602,978 | 241,490,715 |
| Diluted Average Shares | 239,955,762 | 241,669,487 | 244,664,263 | 248,608,460 |
ADMA BIOLOGICS, INC. (ADMA)
ADMA BIOLOGICS, INC. (ADMA)